EU/US Properties Organoleptics Cosmetics Suppliers Safety Safety in use Safety references References Other Blenders Uses Occurrence Synonyms Articles Notes

cholesteryl nonanoate
cholest-5-ene-3-beta-yl nonanoate

Supplier Sponsors

Name:[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] nonanoate
CAS Number: 1182-66-7Picture of molecule3D/inchi
Other(deleted CASRN):248258-85-7
ECHA EINECS - REACH Pre-Reg:214-658-3
Beilstein Number:3179820
XlogP3-AA:12.70 (est)
Molecular Weight:526.88854000
Formula:C36 H62 O2
BioActivity Summary:listing
NMR Predictor:Predict (works with chrome, Edge or firefox)
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Google Scholar:Search
Google Books:Search
Google Scholar: with word "volatile"Search
Google Scholar: with word "flavor"Search
Google Scholar: with word "odor"Search
Google Patents:Search
US Patents:Search
EU Patents:Search
Pubchem Patents:Search
Physical Properties:
Assay: 95.00 to 100.00
Food Chemicals Codex Listed: No
Boiling Point: 576.00 to 577.00 °C. @ 760.00 mm Hg (est)
Flash Point: 573.00 °F. TCC ( 300.80 °C. ) (est)
logP (o/w): 14.108 (est)
Soluble in:
 water, 2.659e-009 mg/L @ 25 °C (est)
Organoleptic Properties:
Odor and/or flavor descriptions from others (if found).
Cosmetic Information:
CosIng:cosmetic data
Cosmetic Uses: skin conditioning - emollient
BOC Sciences
For experimental / research use only.
Cholesteryl pelargonate >89.0%
Santa Cruz Biotechnology
For experimental / research use only.
Cholesteryl pelargonate
Sigma-Aldrich: Aldrich
For experimental / research use only.
Cholesteryl pelargonate 97%
For experimental / research use only.
Cholesteryl Nonanoate >89.0%(GC)
Safety Information:
Preferred SDS: View
Hazards identification
Classification of the substance or mixture
GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)
None found.
GHS Label elements, including precautionary statements
Hazard statement(s)
None found.
Precautionary statement(s)
None found.
Oral/Parenteral Toxicity:
Not determined
Dermal Toxicity:
Not determined
Inhalation Toxicity:
Not determined
Safety in Use Information:
Recommendation for cholesteryl nonanoate usage levels up to:
 not for fragrance use.
Recommendation for cholesteryl nonanoate flavor usage levels up to:
 not for flavor use.
Safety References:
EPI System: View
AIDS Citations:Search
Cancer Citations:Search
Toxicology Citations:Search
EPA Substance Registry Services (TSCA):1182-66-7
EPA ACToR:Toxicology Data
EPA Substance Registry Services (SRS):Registry
Laboratory Chemical Safety Summary :14448
National Institute of Allergy and Infectious Diseases:Data
WGK Germany:3
[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] nonanoate
 [10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] nonanoate
NIST Chemistry WebBook:Search Inchi
Canada Domestic Sub. List:1182-66-7
Pubchem (cid):14448
Pubchem (sid):134980303
Other Information:
(IUPAC):Atomic Weights of the Elements 2011 (pdf)
Videos:The Periodic Table of Videos
tgsc:Atomic Weights use for this web site
(IUPAC):Periodic Table of the Elements
HMDB (The Human Metabolome Database):Search
Export Tariff Code:2937.29.9090
Potential Blenders and core components note
None Found
Potential Uses:
Occurrence (nature, food, other):note
 not found in nature
 cholest-5-en-3-ol (3b)-, nonanoate
 cholest-5-en-3-yl nonanoate
 cholest-5-ene-3-b-yl nonanoate
 cholest-5-ene-3-beta-yl nonanoate
 cholesterol, nonanoate
 cholesteryl pelargonate
[10,13-dimethyl-17-(6-methylheptan-2-yl)-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] nonanoate
 nonanoic acid, cholest-5-en-3-yl ester


PubMed:Combinatorial approach for the rapid determination of thermochromic behavior of binary and ternary cholesteric liquid crystalline mixtures.
PubMed:Enantioselective separations using chiral supported liquid crystalline membranes.
PubMed:Molecular dynamics in rod-like liquid crystals probed by muon spin resonance spectroscopy.
PubMed:Supercooled smectic nanoparticles: influence of the matrix composition and in vitro cytotoxicity.
PubMed:Viscosity peaks at the cholesteric-isotropic phase transitions.
PubMed:Manufacturing factors affecting the drug delivery function of thermo-responsive membrane prepared by adsorption of binary liquid crystals.
PubMed:Precision and reproducibility of temperature response of a thermo-responsive membrane embedded by binary liquid crystals for drug delivery.
PubMed:Adiabatic scanning calorimetric results for the blue phases of cholesteryl nonanoate.
PubMed:[Use of liquid-crystal cutaneous thermography for the diagnosis of bone diseases].
PubMed:Characteristics of liquid crystal devices with improved response times.
PubMed:Crystal structure of cholesteryl decanoate.
PubMed:[Dielectric properties of the mixture of cholesteryl nonanoate and cholesteryl chloride (author's transl)].
PubMed:Transitions in mesophase-forming systems. 3. Transformation kinetics and textural changes in cholesteryl nonanoate.
PubMed:Selected optical properties of mixtures of cholesteric liquid crystals.
None found
Please share your Comments.
Email Address:
Top of Page Home
Copyright © 1980-2021 The Good Scents Company (tgsc) ™ Disclaimer Privacy Policy